LOCKHEED MARTIN INVESTMENT MANAGEMENT CO
Position in MRK — Merck & Co., Inc.
CIK 897599
BETHESDA, MD
Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,176,250
-$6,565,647 QoQ
Shares Held
32,500
-63.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,125
of 3,769 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOCKHEED MARTIN INVESTMENT MANAGEMENT CO holds $85,820,334 across 7 Drug Manufacturers - General names. MRK ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
171,210 | $43,482,203 | |
| 2 | LLY |
ELI LILLY & Co
|
13,090 | $15,700,540 | |
| 3 | ABBV |
AbbVie Inc.
|
41,130 | $10,349,953 | |
| 4 | NVS |
Novartis AG
|
48,400 | $7,585,248 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
32,500 | $4,176,250 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,100 | $3,044,794 | |
| 7 | NVO |
Novo Nordisk A S
|
30,900 | $1,481,346 |
All Filings in MRK
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,176,250 | 32,500 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $10,741,897 | 89,300 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $9,873,388 | 93,800 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $11,859,309 | 141,300 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $10,773,676 | 136,100 | Shares | Sole | 2025-08-04 | |
| 2024-12-31 | $3,730,500 | 37,500 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,567,128 | 13,800 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $866,600 | 7,000 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||